Ritlecitinib
| CAS No. | 1792180-81-4 | Cat. No. | BCP24778 |
| Name | Ritlecitinib | ||
| Synonyms | PF06651600;PF 06651600;PF-06651600; | ||
| Formula | C15H19N5O | M. Wt | 285.34 |
| Description | Ritlecitinib is an orally available small-molecule inhibitor of tyrosine-protein kinase JAK3 (Janus kinase 3; JAK3) with potential immunomodulatory and anti-inflammatory activities. | ||
| Related Products | 2192215-81-7（Ritlecitinib tosylate） | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway Wnt/Stem Cell Epigenetics | ||
| Targets | JAK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.